B-cell therapy uses drugs called monoclonal antibodies to attack white blood cells known as B cells that cause nerve damage. The FDA has approved three such drugs for MS. Ocrelizumab (Ocrevus)treats ...

B-cell therapy (sometimes called B-cell depletion) often works well to keep multiple sclerosis (MS) from getting worse. But these treatments can also be expensive. Fortunately, health insurance ...

B cells and antibodies account for the most prominent immunodiagnostic feature in patients with multiple sclerosis (MS), namely oligoclonal bands. Furthermore, evidence is accumulating that B cells ...